Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,461,676
-$5,914,656 QoQ
Shares Held
652,530
-48.3% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 323 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. ADMA ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ADMA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,461,676 | 652,530 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,376,332 | 1,262,634 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,955,007 | 1,532,621 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $40,614,679 | 2,770,442 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $57,289,625 | 3,146,053 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $70,411,921 | 3,548,988 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $64,653,579 | 3,769,888 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $73,307,248 | 3,667,196 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $28,868,269 | 2,582,135 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,246,431 | 2,007,035 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,781,866 | 1,057,935 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,999,666 | 1,396,555 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,478,682 | 1,213,735 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,221,407 | 973,235 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,700,227 | 695,935 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,551,312 | 638,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,436,490 | 725,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $963,861 | 526,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $491,949 | 348,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $265,550 | 235,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $281,001 | 175,626 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||